share_log

华领医药-B(02552.HK)3月28日举行董事会会议考虑及通过全年业绩

Hualing Pharmaceutical-B (02552.HK) held a board meeting on March 28 to consider and approve the annual results

Gelonghui Finance ·  Mar 18 01:35

Gelonghui, March 18 | Hualing Pharmaceutical-B (02552.HK) announced that the company will hold a board meeting on March 28, 2024 (Thursday) to consider and approve, including the Group's annual results for the year ended December 31, 2023, and the proposed final dividend (if any), and other matters.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment